Timothy Showalter, University of Virginia Health System (IMAGE)
Caption
University of Virginia Cancer Center radiation oncologist Timothy Showalter has determined that offering brachytherapy for advanced cervical cancer ends up costing hospitals money. This may explain its declining use even though it's the gold-standard treatment.
Credit
UVA Health System
Usage Restrictions
May be used by reporters and webmasters to accompany news coverage of the cervical cancer cost study. All other uses require express written permission from UVA Health System.
License
Licensed content